Ionis Pharmaceuticals
IONS
#1567
Rank
$13.23 B
Marketcap
$81.68
Share price
-0.16%
Change (1 day)
114.33%
Change (1 year)

Revenue for Ionis Pharmaceuticals (IONS)

Revenue in 2025 (TTM): $0.96 Billion USD

According to Ionis Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is $0.96 Billion USD. In 2024 the company made a revenue of $0.70 Billion USD a decrease over the revenue in the year 2023 that were of $0.78 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ionis Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.96 B37.13%
2024 $0.70 B-10.48%
2023 $0.78 B34.1%
2022 $0.58 B-27.53%
2021 $0.81 B11.13%
2020 $0.72 B-35.04%
2019 $1.12 B87.2%
2018 $0.59 B15.61%
2017 $0.51 B49.64%
2016 $0.34 B22.18%
2015 $0.28 B32.47%
2014 $0.21 B45.4%
2013 $0.14 B44.33%
2012 $0.10 B2.99%
2011 $99.08 M-8.65%
2010 $0.10 B-10.8%
2009 $0.12 B23.83%
2008 $98.2 M41.05%
2007 $69.62 M183.81%
2006 $24.53 M-38.88%
2005 $40.13 M-5.84%
2004 $42.62 M-14.73%
2003 $49.98 M-37.65%
2002 $80.17 M50.51%
2001 $53.27 M43%
2000 $37.25 M9.9%
1999 $33.9 M-13.3%
1998 $39.1 M20.68%
1997 $32.4 M43.36%
1996 $22.6 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
$0.13 B-85.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas